Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Randomized Chemoprevention Study of Selenium on the Recurrence of Non-invasive Bladder Cancer

NCT00729287 is registered in ClinicalTrials.gov with KU Leuven as lead sponsor.

NCT NCT00729287
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00729287 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Randomized Chemoprevention Study of Selenium on the Recurrence of Non-invasive Bladder Cancer
Lead sponsor
KU Leuven
Phase
Phase 3
Overall status
Completed
Start date
September 30, 2009
Completion date
December 31, 2015
Enrollment
276 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bladder cancer